Ads
related to: fda
Search results
FDA warns parents about Crecelac infant formula—what parents need to know about the recall
Motherly via Yahoo News· 16 hours agod3sign/Getty/FDA The FDA has issued an alert warning parents to avoid buying formula from a Texas...
‘Frances Oldham Kelsey, the FDA, and the Battle Against Thalidomide’ Review: The Noble Bureaucrat
The Wall Street Journal· 12 hours agoFrances Oldham Kelsey faced a tough choice between two job offers at different federal agencies in...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
ABC News· 13 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...
FDA advisors reject MDMA therapy for PTSD, amid concerns over research
WLRN Miami· 6 hours agoIt represents a major setback for proponents of the drug and Lykos Therapeutics, which sponsored...
FDA sets panel review for IceCure's breast cancer treatment By Investing.com
Investing.com· 13 hours agoThe U.S. Food and Drug Administration (FDA) is set to convene a Medical Device Advisory Committee...
Denali, Neurogene and more picked by FDA's 'Operation Warp Speed' for rare disease
FierceBiotech· 10 hours agoThe FDA’s “Operation Warp Speed” equivalent for rare disease will include programs from Denali...
FDA advisors express skepticism as they debate MDMA therapy for PTSD
WUSF 89.7· 12 hours agoTuesday, scientific advisors to the Food and Drug Administration are deciding whether to recommend...
FDA panel rejects MDMA therapy for treating patients with PTSD
WSB Radio· 5 hours agoAn independent advisory panel of the Food and Drug Administration on Tuesday rejected the use of...
FDA advisory panel votes against allowing MDMA as PTSD treatment
UPI· 3 hours agoThe popular underground drug midomafetamine, also called MDMA and "ecstasy," failed to win an...
Psychedelic drug MDMA faces FDA panel in bid to become first-of-a-kind PTSD medication
WSB Radio· 12 hours agoThe Food and Drug Administration convened a panel of outside experts Tuesday to review the latest...